I'm guilty as charged. I thought management was doing the right things. But that doesn't make it good for the shareholders. Simply, management failed under big pressure. They should have expected the problem from the beginning and sold it right there and then. They did say they were approached by a few pharmas and they didnt want to sell.
lol, you shouldnt have a bunch of diff usernames, maybe I misspoke, but Zogenix will manufacture, but not pay for the manufacturing costs.
you are correct, they only have like 35M shares at $11 a share
their 4th quarter net sales were 54M and 120M for 2014
85% inst ownership
these guys will double in 6 months
its on Pernix website, the PRd the transaction like Zogenix did, they have some details Zogenix didnt include on their PR
that is the better question. when do they start covering, my guess they will start next week and do it over 6-12 months
I added another 20M in case the stock doubles, which it should, they are growing well YOY, From today we own 1.7M of their stock. I dont think Zogenix will sell their share yet. Probably only when money needed. My guess sometimes mid 2016
I mean R&D expenses for Relday and ZX008
100M upfront good, 300M milestones not so, they are hard to reach. My guess 100M in milestones possible over 4 years.
20M in Pernix stock is good, stock will double or triple by next year, they are doing a good job looking at the 2014 EOY filing
12.5M for the altus formulation due next year
So in total by end of 2016 year, Zogenix should have made about 120M + 12.5M altus + 10M in milestone = about 140M over two years.
I think we have a 40M loan that will be repaid in a couple of months, so down to 100M over two years
200 to only 60 employees, very good. burn should go down from $25M to less than 5M
No salesforce, manufacturing Zo paid by Pernix
Relday and ZX008 costs shouldnt be a lot this year, with an increase next year. Probably about 50M till 2016 in expenses for those two
The company is covered, no more dilution.
I'm thinking this trades in $2 range for some time
its actually 100 plus 283 in milestones. some of the milestones are really hard to reach.
im just glad zohydro is gone. this was a really tough sell...stock will trade in the 2 range for a long time
you might be right. Seems like shorts have no clue whats coming, so they are protecting themselves by selling calls
Well, FWIW - couple of weeks ago I heard from an insider that they are close to get the partnership going, but hearing that last presentation makes me think they decided against it and will sell ZO. IMO zohydro could bring between 300-500M - They will make about 40-50 this year on the drug with a salesforce of just 100 people...so someone who can do 500-1000 salesreps could potentially tap a large market and bank a lot of money, def more than 120M a year